About Us
Our Vision
Providing the most innovative inhaled therapies in the world.
Our Story
InhaleRx Ltd is the natural evolution of Lifespot Health Ltd, in 2020 the Board and Management of Lifespot Health recognised that the strategic direction and future focus of Lifespot Health Ltd had changed significantly to the point that the name no longer reflected the companies goals, aspirations and strategic direction.
Lifespot Health Ltd had originally been named to reflect its early clinical focus on screening technology for Skin Cancer. However as Lifespot Health Ltd evolved with the fast changing medical device market, Lifespot Health Ltd’s focus had refocused onto inhaled medicine delivery systems, and hence InhaleRx Ltd was born.
The new name is a combination of “Inhale”, and “Rx” the common shorthand for prescription, which better reflects the company’s focus on medical inhalation devices for the delivery of prescribed medicines.
Our Mission
To deliver the unique benefits of inhaled medication systems to patients in an affordable and high-quality format, supported by strong clinical evidence. We will achieve this by partnering with innovators and educators in their technical and therapeutic fields, to provide inhalation breakthrough therapies that deliver added value for patients, doctors, business partners, governments and stakeholders alike.
Our Values
Innovation
We accept that there ia always a better way, the road to success is in finding it!
Reliability
We do what we say we will do.
Transparency
We communicate clear goals, objectives and outcomes to all stakeholders.
Integrity
Integrity leads our decision making.
CORPORATE GOVERNANCE
Recent legislative changes to the Corporations Act 2001 (Cth) mean there are new options for how InhaleRx Ltd shareholders receive communications. InhaleRx Ltd will no longer send physical meeting documents unless a shareholder requests a copy to be mailed.
Providing your email address to receive shareholder communications electronically
InhaleRx Ltd encourages all shareholders to provide an email address so we can communicate with you electronically when shareholder notices become available online, for items such as meeting documents and annual reports.
By providing your email address, you will;
- Support the company by reducing the cost of mailing/postage
- Receive your investor communications faster and in a more secure way
- Help the environment through the need for less paper
How do I update my communications preferences?
Shareholders can still elect to receive some or all of their communications in physical or electronic form or elect not to receive certain documents such as annual reports. To review your communications preferences, or sign up to receive your shareholder communications via email, please update your communication preferences at https://investor.automic.com.au/
If you are a shareholder and would like a physical copy of a communication, need further information about the options available to you or have questions about your holding, visit https://investor.automic.com.au/ or contact our share registry:
Automic Group
Level 5 126 Phillip Street
Sydney NSW 2000
Telephone (within Australia): 1300 288 664
Telephone (outside Australia): +61 2 9698 5414
Email: hello@automicgroup.com.au
Website: https://investor.automic.com.au/
